Abstract
In human colorectal cancer, K-ras point mutations occur in approximately 40-50% of the cases, a frequency second only to pancreatic cancer (80-90%). Unlike pancreatic and lung cancers, however, the tumor-suppressive effect of antisense K-ras RNA expression has not been examined for colorectal cancers. A recombinant adenovirus vector expressing an antisense or sense K-ras gene fragment (AxCA-AS-K-ras or AxCA-S-K-ras) was first transduced into seven human colorectal cancer cell lines. Stable expression of antisense or sense K-ras RNA was detected by RNA blot analysis. Western blot analysis confirmed a reduction of up to 25% of K-ras-specific p21 protein in the antisense K-ras-transduced HCT-15 cells. In contrast to our previous findings on pancreatic cancer, the status of K-ras point mutations was not correlated with the growth-suppressive effect of the antisense K-ras vector: both the K-ras-mutation-positive and -negative colorectal cancer cell lines were suppressed for their growth in vitro. There was no growth-inhibitory effect on normal cells such as hepatocytes. Next, to test the efficacy in vivo, HCT-15 cells were inoculated subcutaneously into the left flank of SCID mice, and AxCA-AS-K-ras was injected intratumorally three...Continue Reading
References
Dec 15, 1991·Gene·H NiwaJ Miyazaki
Mar 15, 1991·Cancer Research·T MukhopadhyayJ A Roth
Jun 1, 1990·Cell·E R Fearon, B Vogelstein
Jul 15, 1989·Gene·J MiyazakiK Yamamura
Apr 1, 1989·The Surgical Clinics of North America·K HughesP H Sugarbaker
May 1, 1988·Mutation Research·J L Bos
Jun 1, 1985·Journal of Virology·I SaitoH Shimojo
Aug 11, 1983·Nature·D J CaponD V Goeddel
Oct 11, 1995·Nucleic Acids Research·Y KanegaeI Saito
Jan 1, 1995·CA: a Cancer Journal for Clinicians·P A WingoS Bolden
Aug 1, 1995·Anti-cancer Drugs·C SakakuraT Takahashi
Feb 1, 1995·Human Gene Therapy·W W ZhangJ A Roth
Jun 1, 1994·Japanese Journal of Medical Science & Biology·Y KanegaeI Saito
Aug 1, 1993·Human Gene Therapy·Y ZhangJ A Roth
Feb 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·S MiyakeI Saito
Sep 1, 1996·Nature Medicine·J A RothD Cai
Jul 1, 1996·Seminars in Surgical Oncology·Y FongA M Cohen
May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·F OkadaR S Kerbel
Oct 6, 1998·Human Gene Therapy·M SchulerC Huber
Jul 31, 1999·Human Gene Therapy·J L CollM Favrot
Aug 10, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·K AokiG J Nabel
Citations
Apr 6, 2006·Oligonucleotides·Miroslava OgorelkovaBernard Massie
Mar 31, 2015·Artificial Cells, Nanomedicine, and Biotechnology·Ying ZhangYong Sun
Apr 10, 2004·Cancer Science·Teruhiko YoshidaKazunori Aoki
Jan 20, 2007·Cancer Science·Hidehiko HaraKazunori Aoki
Jan 11, 2005·Cancer Letters·Yoshiaki MiuraKazunori Aoki
Sep 19, 2003·Biochemical and Biophysical Research Communications·Shumpei OhnamiTeruhiko Yoshida
Dec 15, 2010·Journal of Hepatology·Maria A González-CarmonaWolfgang H Caselmann
Sep 29, 2004·The Journal of Gene Medicine·Kazuteru HatanakaKazunori Aoki
Aug 18, 2005·British Journal of Cancer·M OhashiK Aoki
Sep 2, 2003·The Journal of Nutrition·L M Knowles, J A Milner
Nov 14, 2018·Cancer Gene Therapy·Aya HirataKazunori Aoki